CD8A and neoplasm: RT causes the release of tumor antigens, which leads to increased tumor antigen presentation, thereby recruiting and activating antitumor subsets, such as CD4+ and CD8+ T cells, cytotoxic NK cells, and CD8+ CD56+ natural killer T (NKT) cells (14).